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Anxiety and depression can increase the intensity of dyspnea out of proportion to the impair-
ment in cardiorespiratory function and may contribute to the degree of disability associated
with dyspnea. The effect of anxiety/depression on the sensory and affective components of
reported dyspnea in patients with respiratory disorders might be of particular importance in
improving the accuracy of the diagnostic process. However, the exact cause-relationship be-
tween dyspnea and anxiety/depression are unclear. A multidimensional model of dyspnea sub-
suming sensory components (i.e. intensity and quality) and affective components has recently
been proposed. Affective responses drive patients to seek treatment which can cause them to
alter their lifestyle to avoid dyspnea. Brain imaging techniques help identify distinct cortical
structures involved in processing the discrete components of dyspnea.
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The influence of emotional states on symptom perception in
respiratory disease is a topic of growing interest to re-
searchers and clinicians. Patients with chronic lung disease
who suffer from dyspnea often exhibit anxiety or depressive
symptoms.1e4 These emotional states have been shown to
predict poorer quality of life and functional status5e11 and
likely contribute to the degree of disability associated with
dyspnea and increased use of medical services.12 Emotional
states may shape the quality and intensity of dyspnea at
a given level of respiratory activity and partly explain why
the relationship between dyspnea and the degree of
impairment in lung function is not strong.13 Although anxiety
and depression may lead to worsening of dyspnea, the exact
cause relationships and direction of causality between dys-
pnea and anxiety/depression are unclear.14,15
Surprisingly, despite frequent discrepancies between res-
piratory patients’ self-reported dyspnea and the extent of
underlying pathophysiology, few studies have investigated the
effect of psychopathology on ratings of perceived dyspnea by
applying psychophysical methods, that is, the quantitative
study of the relationship between stimuli and the evoked
conscious sensory response. A critical appraisal of symptoms
can only come with application of psychophysical techniques
applied within the framework of respiratory and sensory
physiology. As with pain, dyspnea should been measured
adequately. A consensus statement of the American Thoracic
Society (ATS)13 has recently proposed that “instruments or
section of instruments pertaining to dyspnea should be clas-
sified as addressing domains of sensory-perceptual experi-
ence, affective distress, or symptom/disease impact or
burden”. Sensory-perceptual measures include ratings of in-
tensity (real-time dyspnea measures), and sensory quality.
Affective distress can pertain to either a perception of im-
mediate unpleasantness or to a cognitive-evaluative response
to or judgment about the possible consequence of what is
perceived. Impact measures, although very important, do not
directly assess “what breathing feels like”.13
This review focuses on the following: (i) The effect of
anxiety/depression on perceived dyspnea in health and
disease, (ii) Differentiation between sensory and affective
components in patients with respiratory disorders, and (iii)
Brain processing of the discrete components of dyspnea.Effects of emotional states on dyspnea
perception
Chronic obstructive pulmonary disease (COPD)
The greatest attention has been focused on the psychological
parameters of COPD.15e17 A systematic review of 64 studiesfocusing on patients with severe disease, indicated that the
level of anxiety and depression in COPD patients was com-
parable to or higher than the levels detected in cancer, AIDS,
renal and cardiac patients.17 The question arises as to
whether anxiety and depression can intensify dyspnea out of
proportion to the level of impairment evidenced by the car-
diorespiratory function.18,19 Dahlen et al.20 investigated
whether psychological factors assessed by the hospital anxi-
ety and depression (HAD) scale were correlated to the risk of
relapse in patients with acute exacerbation of asthma and
COPD. In their series patients with probable anxiety and/or
depression had the same dyspnea score as patients without
anxiety or depression. Also, the risk of treatment failure was
significantly related to HAD, but not to dyspnea. More
recently, it has been shown that the degree of chronic exer-
tional dyspnea assessed by a graded scale does not differ
between non-depressed and depressed COPD patients11 with
similar levels of airway obstruction but a greater level of
anxiety in the latter group. Other studies15 have shown a sig-
nificant association between anxiety/depression (HAD scale)
and increase in intensity of dyspnea at rest and after 6 min
walking test in patients with mild to moderate COPD. A pul-
monary rehabilitation program (PRP) reduced both dyspnea
and anxiety/depression but this association remained stable
over the course of PRP even when improvements in the out-
comes were achieved during PRP.15 In addition the negative
association between anxiety/depression and dyspnea is not
thought to provide proof of causality between these vari-
ables.15 Further studies are needed to determine a specific
cause-effect relationship.
A recent study has shown that the presence of panic at-
tacks (i.e. acute intense anxiety associated with physical
symptoms and cognitive fears) or panic disorders in in-
dividuals with COPD may be associated with a heightened
perception of dyspnea.14 Livermore et al.14 compared the
perceptual response to a resistive load in COPD patients with
panic attack (PA) or panic disorders (PD) and healthy sub-
jects. The dyspnea rating increased linearly for all groups
with increasing the resistive load. Patients with PA or PD
rated their level of dyspnea significantly higher than did
other subjects. In addition, the higher the levels of depres-
sion between the groups, the greater the rating of dyspnea
as the magnitude of resistive load increased. So the diagnosis
of panic attack/disorder should be carefully considered in
patients with respiratory obstructive disorders.
Asthma
Janson et al.21 have documented correlations between
depression/anxiety (HAD scale) and the report of asthma-
related symptoms, such as attacks of breathlessness during
rest and activity, and waking with either attacks of breath-
lessness or chest tightness. On the other hand, Chetta et al.22
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profile by applying the Minnesota Multiphasic Personality In-
ventory (MPI) questionnaire, and perceived dyspnea on a Borg
scale at 20% FEV1 (forced expiratory volume in 1 s) fall during
a bronchial provocation test. By contrast, significantly higher
levels of perceived breathlessness have been reported during
induced bronchoconstriction in asthmatics with comorbid
panic disorders.23 In patients with near-fatal asthma psycho-
logical disturbancesmight affect asthma control. In a study by
Boulet et al.24 patientswith near-fatal asthmaexhibitedmore
psychological problems than the non-asthmatic group. How-
ever, an increase in Borg was associated with a concurrent
decrease in peak expiratory flow (PEF %pred) similarly in the
two groups. Also, perception of dyspnea on a Borg scale at 20%
fall in FEV1 duringmethacholine-induced bronchoconstriction
was similar in near-fatal and non-near-fatal asthma groups (3
vs 2.5, Borg units, respectively).
Although the ventilatory response to inspiratory loads is
governed primarily by respiratory system mechanics and re-
flexes, behavioral or cognitive factors may play a role in this
response as well. Lavietes et al.25 hypothesised that patients
with a specific psychological trait will associate a greater
degree of dyspnea during loaded breathing task than other-
wise healthy control subjects. They recruited subjects with
Chronic Fatigue Syndrome (CFS), and normal healthy sub-
jects. The choice of CFS was motivated by the fact that
somatisation was thought to explain in part the symptom of
CFS. Subjects were divided into two groups. The “responder”
group reported Borg scores higher than those of the second
“non responder” group at all times during resistive breathing
protocol. Responders presented higher depression scores
(Center for Epidemiologic Study depression scale) than did
non-responders. Of note a greater percentage of patients
(42%) with psychological problems were in the “responder”
group than in the “non-responder” group (17%). On the other
hand, no differences on depression scale were found in
control subjects, regardless of load response. Thus the
diagnosis of panic attack/disorder should be carefully con-
sidered in patients with severe respiratory obstructive
disorders.Affective components of dyspnea and brain
processing
Any assessment of dyspnea should try to measure the in-
tensity and quality of the sensation of respiratory dis-
comfort and the emotional and behavioral response to the
breathing discomfort.13 Pivotal studies26e28 have provided
compelling evidence that sensory intensity and the un-
pleasantness of pain are discrete dimensions since they can
be independently manipulated in laboratory and clinical
situations. They even appear to be subserved by separate
neural pathways, a lateral thalamic system that projects to
the primary sensory cortex and subserves sensory aspects,
and a medial thalamic system that projects to the limbic
cortex and subserves affective aspects.26 Further develop-
ment regarding the affective dimensions of pain has
been divided into an initial stage A1 of immediate un-
pleasantness or discomfort, and later stage A2 of cogni-
tively mediated emotional reactions such as depression,
anxiety, fear, etc., that may lead to behavioral outcomes.28Recently, brain image techniques have been used to iden-
tify distinct cortical structures and pathways that have
been shown to be more involved in either sensory or af-
fective aspects of pain.27,29 It has been postulated (but not
definitely proven) that these structures might also process
the discrete components of dyspnea.30,31 In this regard
Davenport and Reep32 have described the two major
pathways suggested to process respiratory sensation to the
sensory cortex. The first pathway arises predominantly
from respiratory muscle afferents, is relayed to the brain-
stem medulla, and projects to the ventroposterior thalamus
area, from where thalamocortical projections ascend to the
primary and secondary somatosensory cortex. The second
pathway includes mainly vagal afferents from the lungs and
airways which are relayed in the brainstem medulla.
Brainstem projections ascend to the amygdala and medial
dorsal area of the thalamus and further to the insula and
cingulate cortex.
First evidence has suggested similar multidimensionality
in the perception of both pain and dyspnea.29e33 Von Leu-
poldt and Dahme34 have recently shown in healthy subjects
breathing against increased inspiratory loads that with
increasing intensity of dyspnea the perceived unpleasantness
increased stronger than the perceived intensity, indicating
that the sensory and the affective dimensions of dyspnea can
be differentiated similarly to the perception of pain.
These findings help clarify and explain old and recent
data. Boulet et al.35 were able to show that perception of
airflow obstruction and breathlessness following meth-
acholine challenge testing were correlated with each other.
Mean perception scores were higher for asthmatics than
controls but anxiety levels during methacholine was low in
both groups and did not correlate with dyspnea. However,
it must be noted that perception of airway obstruction was
defined as a sensation of a change in breathing pattern
while dyspnea was defined as an unpleasant sensation
associated with bronchoconstriction. We argue against this
contention as unpleasantness is likely to define the affec-
tive component while intensity of dyspnea (Borg scale)
defines one of the two aspects of the sensory component.
More recently De Peuter et al.36 have calculated the
linear slope between a 20% fall in FEV1 and the increase in
the symptom scores of intensity and affectivity during
a histamine bronchial provocation test in patients with
asthma. Sensitivity appears to be positively related to trait
anxiety, state anxiety, daily asthma symptoms and cata-
strophic thinking during an asthma exacerbation in daily
life. These relationships were overall stronger for affective
than for sensory symptom slopes. By applying stepwise
multiple regression analysis, the state of anxiety was the
best predictor of the affective symptom slopes, whereas
catastrophic thinking during an asthma exacerbation was
the best predictor for the sensory symptom slopes. In
contrast, the relation between state anxiety and sensory
symptoms was not significant. These results have clinical
implications. A high sensitivity seems favorable because it
allows the early detection of deteriorating lung function
and quick medication relief. A moderate degree of asthma-
specific anxiety is adaptive because it may be associated
with enhanced perception of bronchoconstriction. In con-
trast, absence of anxiety may lead to indifference and
neglect of symptoms.37
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components of reported dyspnea in patients with comorbid
depression might be of particular importance and improve
the accuracy of the diagnostic process, symptom perception,
and therapeutic interventions. This has been pointed out in
previous studies36,38,39 demonstrating that high negative
affectivity reduces the accuracy of global rating of dyspnea
perception. This might lead to an increased use of health
care resources to find relief from the overly negatively
perceived symptom. Put et al.39 found that asthmatics with
high negative affectivity had overall more intense dyspnea
than patients scoring low affectivity; in addition negative
affectivity modulated the effects of suggestions on dyspnea.
In this regard, Davenport et al.,40 used respiratory-related
evoked potential (RREp) methodology in a group of asth-
matic children with a story of life-threatening asthma. They
found an absence of P1 component after respiratory occlu-
sion (i.e. the dyspneic sensory signal was not activating the
somatosensory cortex). These data suggest the presence of
an asthma-specific deficit in the latter cortical processing of
respiratory load information. Nonetheless, it might be
interesting in this regard to examine whether patients with
blunted perception of dyspnea have a specific deficit in the
affective rather than the sensory aspects of their perceptual
processing.
A multidimensional model of dyspnea subsuming sensory
components (i.e. intensity and quality) and affective com-
ponents has recently been proposed.33,41 Affective responses
are a major stimulus for learning strategies to avoid bio-
logically threatening sensations; they also drive patients to
seek treatment and can cause them to alter their lifestyle to
avoid dyspnea. An exaggerated perception of dyspnea,
which may lead to excessive use of medical resources, may
be an over-response in the affective dimension. In this
connection, it has been hypothesised that the affective
dimension of dyspnea (unpleasantness, emotional response)
does not strictly depend on the intensity of dyspnea. Banzett
and co-workers41 tested the hypothesis that the ratio of
immediate unpleasantness (A1) to sensory intensity (SI)
would vary, depending on the type of dyspnea. Three dif-
ferent stimuli were applied to healthy subjects. The first
(maximal hyperpnea against inspiratory resistance) evoked
work and effort sensations with relatively low unpleasant-
ness (mean A1/SIZ 0.64). The second stimulus (hypercapnia
with restricted ventilation), titrated to produce dyspnea
ratings similar to those obtained by applying the first stim-
ulus; it evoked air hunger and produced significantly greater
unpleasantness (mean A1/SI Z 0.95). The third stimulus
(further increase of the second stimulus, maximal hypopnea)
was even higher until air hunger was intolerable, evoking the
highest intensity and unpleasantness ratings and ratio
(A1/SI Z 1.09). The data show that: 1. unpleasantness of
dyspnea can vary independently from perceived intensity,
this is consistent with the prevailing model of pain, 2. mul-
tiple dimensions of dyspnea exist and can be measured.
Determining whether a change in dyspnea reflects a change
in the primary sensation or an affective response may inform
us about the role of the psychological state of the patient in
ratings respiratory discomfort and help guide therapies so as
to reduce the A1/SI ratio and subsequent discomfort.
Additional studies from von Leupoldt et al.42 in healthy
subjects breathing against inspiratory load during attentionand distraction indicate that while subjects attend their
breathing only intensity score on VAS influences Borg scale
ratings. In contrast, only the VAS unpleasantness scores
influences Borg scale rating when subjects are distracted.
Directing the patient’s attention away from respiratory
sensation decreases unpleasantness but not intensity, even
if the difference in A1/SI is quite small.
Carrieri-Kohlman et al.43 have shown no correlation be-
tween patients’ state of anxiety and their anxiety associated
with dyspnea during treadmill testing. Also, exercise training
decreased dyspnea and related anxiety. These data indicate
that the decrease in anxiety is specific for dyspnea and not
related to a decrease in overall anxiety. The same group
demonstrated that in COPD patients the relationship be-
tween affective and sensory dimensions can be changed
within individual subjects. The authors pointed out that
a supervised exercise training program reduced dyspnea-
related anxiety more than the intensity of breathing
effort.44 This also suggests that the affective state can limit
a patient’s exercise tolerance during pulmonary rehabil-
itation, by reducing its beneficial effect.45
Negative affective states, when compared with positive
affective states, increase the perception of dyspnea during
cycling exercise in patients with COPD. The affective un-
pleasantness of dyspnea during exercise is predictive of
a greater symptom burden in patients’ everyday life and
a greater reduction in their health-related quality of life.46
In other words, those patients experiencing their dyspnea
as very unpleasant showed greater symptom burden in their
everyday life. No such effect was found for sensory in-
tensity of dyspnea.
Limbic structures have been identified as brain structures
involved in the perception of pain.27,29 Banzett et al.30,47
and Evans et al.48 speculated that limbic structures were
also involved in the perception of dyspnea. They found
activation of mid/anterior insula during severe air hunger. In
a functional imaging study (Pet) Peiffer et al.49 were able to
identify an area in the right posterior cingulated cortex
during loaded breathing-induced dyspnea which they
hypothesised to be associated with affective cognitive fac-
tors. Several regions in the posterior cingulated gyrus have
indeed been previously been shown to be activated by var-
ious predominantly unpleasant sensory affective functions
such as pain, emotion, anxiety, and related symptoms. Von
Leupoldt et al. investigated the cortical area associated with
the processing of affective unpleasantness of dyspnea by
magnetic resonance imaging (MRI) in healthy subjects.50
Dyspnea was induced by inspiratory resistive breathing
with concomitant positive and negative emotional stimula-
tion. The BOLD (blood oxygen level-dependent contrast)
technique showed that negative emotional situations were
associated with similar levels of intensity but higher un-
pleasantness of dyspnea when compared with concomitant
positive emotional stimulation.50 Higher unpleasantness was
associated with neural activation of limbic system (anterior
insula and amygdala). The data suggest that unpleasantness
but not intensity is processed in the human anterior insula
and amygdala, and that different pathways might process
affective and sensory dimensions of perceived dyspnea.50
The same group51 has recently shown that lesions of the
right anterior insula cortex are associated with reduced
sensitivity for the perception of dyspnea and pain, especially
Dyspnea and emotional states in health and disease 653for their perceived unpleasantness. This study supports the
theoretical assumption of a dual cortical processing of res-
piratory signals of dyspnea.
Von Leupoldt et al.52 have also shed light on the underlying
brain mechanisms of perceived dyspnea in patients with
asthma. Using function fMRI, they compared neural responses
to experimentally-induced dyspnea by resistive load breath-
ing and brain activation with neural responses evoked by heat
pain inducedbycontact thermode inpatientswithasthmaand
healthy controls. Patients and controls rated the sensory in-
tensity of both sensations similarly, while the affective un-
pleasantness of dyspnea and pain was reduced only in
asthmatic patients. The perceptual differences were mir-
rored by a decrease in insula cortex activity, but with an
increase in periaqueductal gray activity in asthmatic patients
during both increased dyspnea and pain.52 These results sug-
gest a down-regulation of affect-related insula cortex activity
by periaqueductal gray activity during both sensations in pa-
tientswith asthma.Moreover, a longerdurationofasthmawas
correlated with a greater decrease in insula cortex response
during increasing dyspnea. According to these authors this
might represent a brain habituation mechanism that reduces
the affective unpleasantness of dyspnea in patients withmild
to moderate asthma. It is worth noting that reduced brain
activation during dyspnea might constitute an important risk
factor in asthma. In a more recent study of the same group53
a negative relationship was found between increased vol-
ume of periaqueductal gray and reduced reports of affective
unpleasantness. These alterations are likely to contribute to
the blunted perception of dyspnea, at least in patients with
mild to moderate asthma. In turn, increased periaqueductal
gray activity might lead to increased inhibition of dyspneic
sensory afferent to the insular cortex with reduced insular
activation without structural change in this area. It is not
understood, however, how the insula gives rise to perceptions
of breathlessness. Given the complexity of the sensation,
activation of the insular cortex during dyspnea probably oc-
curs in concert with a larger neural network functioning with
the insula to mediate dyspnea perception.29,31,48,54
Neural circuitry underlying stress and emotion can regulate
inflammation,55,56 andperipheral inflammatorymediators can
influence mood and cognitive function.57 The body of evi-
dence establishes bi-directional causal links between inflam-
mation and psychological state.58 Asthma, like many
inflammatory disorders, is affected by psychological stress-
suggesting that reciprocal modulation may occur between
peripheral factors regulating inflammation and the central
neural circuitry underlying emotionand stress reactivity.59The
neural circuitry involved remains, however, elusive and con-
jectural. Rosenkrantz et al.59 used the late phase component
of an allergic reaction as a model to identify brain regions
activated by emotional and physiological cues. Using fMRI,
they showed that activity of the anterior cingulated cortex
(ACC) and insula to asthma-relevant emotional stimuli is
associated with markers of inflammation and airway obstruc-
tion in asthmatic subjects exposed to antigen. In particular,
greater signal changes in the ACC and insula in response to
antigen asthma-relevant stimuli are associated with larger
increase in eosinophils and are correlated negatively with
FEV1. According to Rosenkranz et al.
54,59 these results suggest
a neural basis for emotion-induced modulation of airway dis-
ease in asthmatic patients. More recently the same groupmeasuredneural signal (fRMI) in response toasthmaemotional
cues, following allergen exposure in asthmatics with a dual
response to allergen challenge, asthmatics with only an im-
mediate response and healthy controls. Insula was activated
by asthma-relevant cues (emotional stimuli) compared to
general negative cues during the latephase of dual response in
asthmatics.60 Like in the previous study59 the degree of this
differential activation predicted changes in airway inflam-
mation and the decrease in lung function. These findings
suggest that changes inneural activityare likely to reflect both
afferent and efferent processes. If the late phase response to
allergen depends, at least in part, on neural responsivity to
disease-relevant information, then reducing this responsivity
should decrease the magnitude of the latter phase response.
Thus far, whether functional brain imaging of the interaction
between emotion and inflammation reflects an asthma neu-
rophenotype remains to be defined.Conclusions
Anxiety/Depression are likely contributors to the degree of
disability associated with dyspnea in patients with chronic
respiratory disease. However, a reciprocal interaction be-
tween the perception of Anxiety/Depression and dyspnea
should be taken into account. A differentiation between
the sensory and affective components of the reported
dyspnea in these patients might be of particular importance
and improve the accuracy of the symptom perception.
Neuroimaging studies have shed light on the brain networks
involved in the perception of sensory and affective com-
ponents of dyspnea. Whether this can contribute to the
development of more effective therapeutic strategies for
dyspneic patients remains to be elucidated.Conflict of interest
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